We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Ironwood Study

A Phase 2 Study of IW‑3300 for the Treatment of Bladder Pain in Subjects with Interstitial Cystitis/Bladder Pain Syndrome

African American woman holding head

 

AGE: 18+ years old
GENDER: Female
HEALTHY PARTICIPANTS: No
TYPE: Interventional Treatment
CONDITION: Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
LOCATION: University Hospitals Medical Centers
COMPENSATION: Yes

Learn More About This Research Study

For more information, please contact the study coordinator, Alyssa Mason, PhD at 440-995-3811 or by completing the form below.

Study Purpose

The purpose of this study is to assess the efficacy, safety, and tolerability of IW‑3300, an investigational drug for the treatment for interstitial cystitis/bladder pain syndrome (IC/BPS) administered once daily as a rectal foam.

Who Can Participate

Premenopausal women 18 years of age or older with interstitial cystitis/bladder pain syndrome may be eligible for this study.

Request More Information

Please complete the form below to be contacted by a study representative and learn more about this study.

XXX-XXX-XXXX
I'm not a robot

  • STUDY20230606
  • SITE00002000